Search
Close this search box.
×
Search
[custom_company_search_form]
Lithium
45.28
0.49%
Gold
2,670.70
0.65%
Copper
4.16
0.1%
Oil
69.67
0.17%
Bitcoin
97,050.26
2.86%
FTSE 100
8,077.97
(0.09%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.20
1.16%
USD/AUD
0.65
0.2%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,670.70
0.65%
Copper
4.16
0.1%
Oil
69.67
0.17%
Bitcoin
97,050.26
2.86%
FTSE 100
8,077.97
(0.09%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.20
1.16%
USD/AUD
0.65
0.2%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,670.70
0.65%
Copper
4.16
0.1%
Oil
69.67
0.17%
Bitcoin
97,050.26
2.86%
FTSE 100
8,077.97
(0.09%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.20
1.16%
USD/AUD
0.65
0.2%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,670.70
0.65%
Copper
4.16
0.1%
Oil
69.67
0.17%
Bitcoin
97,050.26
2.86%
FTSE 100
8,077.97
(0.09%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.20
1.16%
USD/AUD
0.65
0.2%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,670.70
0.65%
Copper
4.16
0.1%
Oil
69.67
0.17%
Bitcoin
97,050.26
2.86%
FTSE 100
8,077.97
(0.09%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.20
1.16%
USD/AUD
0.65
0.2%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,670.70
0.65%
Copper
4.16
0.1%
Oil
69.67
0.17%
Bitcoin
97,050.26
2.86%
FTSE 100
8,077.97
(0.09%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.20
1.16%
USD/AUD
0.65
0.2%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,670.70
0.65%
Copper
4.16
0.1%
Oil
69.67
0.17%
Bitcoin
97,050.26
2.86%
FTSE 100
8,077.97
(0.09%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.20
1.16%
USD/AUD
0.65
0.2%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,670.70
0.65%
Copper
4.16
0.1%
Oil
69.67
0.17%
Bitcoin
97,050.26
2.86%
FTSE 100
8,077.97
(0.09%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.20
1.16%
USD/AUD
0.65
0.2%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,670.70
0.65%
Copper
4.16
0.1%
Oil
69.67
0.17%
Bitcoin
97,050.26
2.86%
FTSE 100
8,077.97
(0.09%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.20
1.16%
USD/AUD
0.65
0.2%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,670.70
0.65%
Copper
4.16
0.1%
Oil
69.67
0.17%
Bitcoin
97,050.26
2.86%
FTSE 100
8,077.97
(0.09%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.20
1.16%
USD/AUD
0.65
0.2%
Hang Seng
19,601.11
(0.23%)

Stock Piper AI Index

Stock Piper AI Index

Subscribe
Lithium
45.28
0.49%
Gold
2,670.70
0.65%
Copper
4.16
0.1%
Oil
69.67
0.17%
Bitcoin
97,050.26
2.86%
FTSE 100
8,077.97
(0.09%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.20
1.16%
USD/AUD
0.65
0.2%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,670.70
0.65%
Copper
4.16
0.1%
Oil
69.67
0.17%
Bitcoin
97,050.26
2.86%
FTSE 100
8,077.97
(0.09%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.20
1.16%
USD/AUD
0.65
0.2%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,670.70
0.65%
Copper
4.16
0.1%
Oil
69.67
0.17%
Bitcoin
97,050.26
2.86%
FTSE 100
8,077.97
(0.09%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.20
1.16%
USD/AUD
0.65
0.2%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,670.70
0.65%
Copper
4.16
0.1%
Oil
69.67
0.17%
Bitcoin
97,050.26
2.86%
FTSE 100
8,077.97
(0.09%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.20
1.16%
USD/AUD
0.65
0.2%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,670.70
0.65%
Copper
4.16
0.1%
Oil
69.67
0.17%
Bitcoin
97,050.26
2.86%
FTSE 100
8,077.97
(0.09%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.20
1.16%
USD/AUD
0.65
0.2%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,670.70
0.65%
Copper
4.16
0.1%
Oil
69.67
0.17%
Bitcoin
97,050.26
2.86%
FTSE 100
8,077.97
(0.09%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.20
1.16%
USD/AUD
0.65
0.2%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,670.70
0.65%
Copper
4.16
0.1%
Oil
69.67
0.17%
Bitcoin
97,050.26
2.86%
FTSE 100
8,077.97
(0.09%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.20
1.16%
USD/AUD
0.65
0.2%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,670.70
0.65%
Copper
4.16
0.1%
Oil
69.67
0.17%
Bitcoin
97,050.26
2.86%
FTSE 100
8,077.97
(0.09%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.20
1.16%
USD/AUD
0.65
0.2%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,670.70
0.65%
Copper
4.16
0.1%
Oil
69.67
0.17%
Bitcoin
97,050.26
2.86%
FTSE 100
8,077.97
(0.09%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.20
1.16%
USD/AUD
0.65
0.2%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,670.70
0.65%
Copper
4.16
0.1%
Oil
69.67
0.17%
Bitcoin
97,050.26
2.86%
FTSE 100
8,077.97
(0.09%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.20
1.16%
USD/AUD
0.65
0.2%
Hang Seng
19,601.11
(0.23%)

Aft Pharmaceuticals Ltd

AFP

ASX

AFT Pharmaceuticals Limited (AFP) is a multinational pharmaceutical company experiencing growth, dedicated to the development, marketing, and distribution of a diverse portfolio of pharmaceutical products spanning various therapeutic categories. These products are strategically distributed through major pharmaceutical channels, including over-the-counter (OTC), prescription, and hospital markets.

Latest Posts

Line Chart with Gradient
Price
$0.000
0.07 (3.26%)
At Close (AEST)
Related Companies
PRESCIENT THERAPEUTICS LIMITED
$PTX
ADALTA LIMITED
$1AD
LTR PHARMA LIMITED
$LTP
PYC THERAPEUTICS LIMITED
$PYC
AVECHO BIOTECHNOLOGY LIMITED
$AVE

Leave a Comment on AFP


Comments for AFP

    Latest Posts

    aft-pharmaceuticals-asx-afp-reports-first-half-2025-financial-results-afp
    Health Care $AFP
    AFT Pharmaceuticals (ASX: $AFP) reports first half 2025 financial resultsCompany sees revenue growth in Australasia but faces international challenges and anticipates improved second half
    November 21, 2024
    aft-pharmaceuticals-asx-afp-reports-increase-in-revenue-but-decline-in-profit-afp
    Health Care $AFP
    AFT Pharmaceuticals (ASX: $AFP) reports increase in revenue but decline in profitAFT Pharmaceuticals sees 4% revenue growth but faces 155% drop in net profit for H1 2024
    November 21, 2024
    aft-pharmaceuticals-asx-afp-reports-record-sales-growth-amid-challenges-afp
    Health Care $AFP
    AFT Pharmaceuticals (ASX: $AFP) reports record sales growth amid challengesAchieves strong Australasian sales growth; anticipates recovery despite temporary international setbacks
    November 21, 2024
    aft-pharmaceuticals-asx-afp-anticipates-operating-loss-amid-market-challenges-afp
    Health Care $AFP
    AFT Pharmaceuticals (ASX: $AFP) anticipates operating loss amid market challengesCompany faces decreased sales in Asia and international markets, plans for recovery in second half
    November 1, 2024
    aft-pharmaceuticals-asx-afp-to-launch-maxigesic-rapid-in-the-united-states-afp
    Health Care $AFP

    AFT Pharmaceuticals (ASX: $AFP) to launch maxigesic® rapid in the united states

    Agreement with Alexso to distribute non-opioid pain management solution in largest pharma market

    June 4, 2024
    aft-pharmaceuticals-asx-afp-releases-audited-financial-statements-afp
    Health Care $AFP

    AFT Pharmaceuticals (ASX: $AFP) releases audited financial statements

    AFT Pharmaceuticals to provide detailed financial performance for the year

    May 23, 2024

    AFP

    $AFP

    AFT Pharmaceuticals (ASX: $AFP) reports first half 2025 financial results

    Company sees revenue growth in Australasia but faces international challenges and anticipates improved second half

    AFP

    $AFP

    AFT Pharmaceuticals (ASX: $AFP) reports increase in revenue but decline in profit

    AFT Pharmaceuticals sees 4% revenue growth but faces 155% drop in net profit for H1 2024

    AFP

    $AFP

    AFT Pharmaceuticals (ASX: $AFP) reports record sales growth amid challenges

    Achieves strong Australasian sales growth; anticipates recovery despite temporary international setbacks

    AFP

    $AFP

    AFT Pharmaceuticals (ASX: $AFP) anticipates operating loss amid market challenges

    Company faces decreased sales in Asia and international markets, plans for recovery in second half

    AFP

    $AFP

    AFT Pharmaceuticals (ASX: $AFP) to launch maxigesic® rapid in the united states

    Agreement with Alexso to distribute non-opioid pain management solution in largest pharma market

    AFP

    $AFP

    AFT Pharmaceuticals (ASX: $AFP) releases audited financial statements

    AFT Pharmaceuticals to provide detailed financial performance for the year

    Related Companies
    MESOBLAST LIMITED
    $MSB
    AROVELLA THERAPEUTICS LIMITED
    $ALA
    CYNATA THERAPEUTICS LIMITED
    $CYP
    TRAJAN GROUP HOLDINGS LIMITED
    $TRJ
    RADIOPHARM THERANOSTICS LIMITED
    $RAD

    ASX News, First
    & Fast.

    By clicking Subscribe, you agree to our Terms & Conditions

    ASX News, First And Fast.

    By clicking Subscribe, you agree to our Terms & Conditions
    © 2024 Stock Piper.
    All rights reserved

    Blog

    Healthcare
    Materials
    Real Estate
    Consumer Staples
    Consumer Discretionary Brief
    Utilities

    Company

    About us
    Terms of use
    Privacy Policy

    Support

    Contact Support

    Socials

    Facebook
    Twitter
    LinkedIn
    © 2024 Stock Piper. All rights reserved

    Blog

    Healthcare
    Materials
    Real Estate
    Consumer Staples
    Consumer Discretionary Brief
    Utilities

    Company

    About us
    Terms of use
    Privacy Policy

    Support

    Contact Support
    © 2024 Stock Piper. All rights reserved
    Social Media Auto Publish Powered By : XYZScripts.com
    Stock Piper AI Index
    Subscribe
    Join FREE Newsletter

    Stock Piper AI Index Coming Soon!

    Join our Newsletter to gain exclusive insight and be notified once we are live.

    By clicking Subscribe, you agree to our Terms & Conditions

    ASX News, First And Fast.

    Get all the latest market updates straight to your inbox.

    By clicking Subscribe, you agree to our Terms & Conditions